Skip to main content

MW 364.4 Da, Purity >99%. DNA topoisomerase I inhibitor (IC50 = 106 nM). Cytotoxic antitumour compound, more potent than camptothecin (ab120115). In vitro and in vivo activity against a broad spectrum of cancers.

Be the first to review this product! Submit a review

Images

Chemical Structure - 10-Hydroxycamptothecin, DNA topoisomerase I inhibitor (AB141071), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - 10-Hydroxycamptothecin, DNA topoisomerase I inhibitor (AB141071), expandable thumbnail

Publications

Key facts

CAS number

64439-81-2

Purity

> 99%

Form

Solid

Molecular weight

364.4 Da

Molecular formula

C20H16N2O5

PubChem identifier

4330531

Nature

Synthetic

Recommended products

MW 364.4 Da, Purity >99%. DNA topoisomerase I inhibitor (IC50 = 106 nM). Cytotoxic antitumour compound, more potent than camptothecin (ab120115). In vitro and in vivo activity against a broad spectrum of cancers.

Key facts

Purity

> 99%

PubChem identifier

4330531

Solubility

Soluble in DMSO to 50 mM.

Biochemical name

(+/-)-10-Hydroxycamptothecin

Biological description

DNA topoisomerase I inhibitor (IC50 = 106 nM). Cytotoxic antitumour compound, more potent than camptothecin (ab120115). In vitro and in vivo activity against a broad spectrum of cancers.

Canonical SMILES

CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O

InChI

InChI=1S/C20H16N2O5/c1-2-20(26)14-7-16-17-11(5-10-6-12(23)3-4-15(10)21-17)8-22(16)18(24)13(14)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3

InChIKey

HAWSQZCWOQZXHI-UHFFFAOYSA-N

IUPAC name

19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

Storage

Shipped at conditions

Ambient - Can Ship with Ice

Appropriate short-term storage conditions

-20°C

Appropriate long-term storage conditions

-20°C

Storage information

Store under desiccating conditions, The product can be stored for up to 12 months

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - 10-Hydroxycamptothecin, DNA topoisomerase I inhibitor (ab141071), expandable thumbnail

    Chemical Structure - 10-Hydroxycamptothecin, DNA topoisomerase I inhibitor (ab141071)

    2D chemical structure image of ab141071, 10-Hydroxycamptothecin, DNA topoisomerase I inhibitor

  • Immunocytochemistry/ Immunofluorescence - 10-Hydroxycamptothecin, DNA topoisomerase I inhibitor (ab141071), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - 10-Hydroxycamptothecin, DNA topoisomerase I inhibitor (ab141071)

    Anti-gamma H2A.X (phospho S139) antibody ab2893 staining γH2A.X in HeLa cells treated with 10-Hydroxycamptothecin (ab141071), by ICC/IF. Increase of γH2A.X nuclear expression correlates with increased concentration of 10-Hydroxycamptothecin, as described in literature.
    The cells were incubated at 37°C for 6 hours in media containing different concentrations of ab141071 (10-Hydroxycamptothecin) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with Anti-gamma H2A.X (phospho S139) antibody ab2893 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com